BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 14971833)

  • 21. [Are the TASC recommendations for diagnosis and treatment of PAOD still relevant?].
    Langhoff R; Schulte KL
    Hamostaseologie; 2006 Aug; 26(3):208-13. PubMed ID: 16906237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Overview of the most frequent clinical manifestations of peripheral arterial occlusive disease in the elderly, its diagnosis and stage-related therapy].
    Ebert D
    Z Arztl Fortbild Qualitatssich; 1997 Sep; 91(6):525-31. PubMed ID: 9441027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localisation and risk factors of peripheral arterial occlusive disease in the female.
    Bauwens F; Duprez D; Van Wassenhove A; Brusselmans F; Clement DL
    Int Angiol; 1989; 8(1):32-5. PubMed ID: 2768956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral vascular disease. Diagnosing and treating the 3 most common peripheral vasculopathies.
    Dillavou E; Kahn MB
    Geriatrics; 2003 Feb; 58(2):37-42; quiz 43. PubMed ID: 12596496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effective, risk-free, evidence-based medicine.
    Matz R
    Arch Intern Med; 2003 Dec 8-22; 163(22):2795; author reply 2795-6. PubMed ID: 14662644
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiology and diagnosis of peripheral arterial disease in patients with chronic kidney disease.
    Ix JH; Criqui MH
    Adv Chronic Kidney Dis; 2008 Oct; 15(4):378-83. PubMed ID: 18805384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral arterial disease: Pathophysiology, risk factors, diagnosis, treatment, and prevention.
    Muir RL
    J Vasc Nurs; 2009 Jun; 27(2):26-30. PubMed ID: 19486852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment strategies in arterial occlusive diseases].
    Bollinger A
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1354-8. PubMed ID: 8272701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy insight: peripheral arterial disease and diabetes--from pathogenesis to treatment guidelines.
    Mohler ER
    Nat Clin Pract Cardiovasc Med; 2007 Mar; 4(3):151-62. PubMed ID: 17330127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Definition of diagnostic-therapeutic procedures in chronic obstructive peripheral arteriopathies. Members of the AOCP Study Group].
    Pedrini L
    Minerva Cardioangiol; 1998 Sep; 46(9):289-90. PubMed ID: 10021848
    [No Abstract]   [Full Text] [Related]  

  • 32. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.
    Abramson BL; Huckell V; Anand S; Forbes T; Gupta A; Harris K; Junaid A; Lindsay T; McAlister F; Roussin A; Saw J; Teo KK; Turpie AG; Verma S;
    Can J Cardiol; 2005 Oct; 21(12):997-1006. PubMed ID: 16234879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Information from your family doctor. Peripheral arterial disease.
    Am Fam Physician; 2004 Feb; 69(3):533. PubMed ID: 14971834
    [No Abstract]   [Full Text] [Related]  

  • 34. Endovascular treatment of the internal iliac artery in peripheral arterial disease.
    Huétink K; Steijling JJ; Mali WP
    Cardiovasc Intervent Radiol; 2008; 31(2):391-3. PubMed ID: 17610115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
    Davies MG; Waldman DL; Pearson TA
    J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
    [No Abstract]   [Full Text] [Related]  

  • 36. Peripheral arterial disease: a review of disease awareness and management.
    Watson K; Watson BD; Pater KS
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Definition of the diagnostico-therapeutic procedures in chronic peripheral obstructive arteriopathy. Guidelines of the Italian Society of Angiology and Vascular diseases (SIAPAV)].
    Pedrini L; Spartera C; Ponzio F; Arosio E; Andreozzi GM; Signorelli S; Scondotto G; Stella A; Todini AR; Coppi G; De Donato G; De Fabritiis A; Rosato E; Urbano O;
    Minerva Cardioangiol; 2000 Sep; 48(9):277-302. PubMed ID: 11125527
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacotherapy and behavioral intervention for peripheral arterial disease.
    Doyle J; Creager MA
    Rev Cardiovasc Med; 2003; 4(1):18-24. PubMed ID: 12684600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral arterial insufficiency: mechanisms, natural history, and therapeutic options.
    Rockson SG; Cooke JP
    Adv Intern Med; 1998; 43():253-77. PubMed ID: 9506185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.